Liang Yu

1.5k total citations · 2 hit papers
33 papers, 701 citations indexed

About

Liang Yu is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Liang Yu has authored 33 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 8 papers in Hepatology and 7 papers in Infectious Diseases. Recurrent topics in Liang Yu's work include Influenza Virus Research Studies (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis C virus research (5 papers). Liang Yu is often cited by papers focused on Influenza Virus Research Studies (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis C virus research (5 papers). Liang Yu collaborates with scholars based in China, United States and United Kingdom. Liang Yu's co-authors include Lanjuan Li, Hainv Gao, Lingling Tang, Jiajia Chen, Xiaoqing Lu, Xiahong Dai, Yixin Zhu, Lijun Chen, Lü Chen and Charlie Xiang and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Human Molecular Genetics.

In The Last Decade

Liang Yu

31 papers receiving 684 citations

Hit Papers

Clinical Study of Mesenchymal Stem Cell Treatment for Acu... 2020 2026 2022 2024 2020 2025 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liang Yu China 14 217 213 139 114 110 33 701
Lai Wei China 15 207 1.0× 114 0.5× 168 1.2× 55 0.5× 42 0.4× 53 653
Liming Liu China 11 108 0.5× 78 0.4× 103 0.7× 63 0.6× 22 0.2× 27 549
Fang Cui China 16 173 0.8× 42 0.2× 174 1.3× 116 1.0× 49 0.4× 44 626
Qingyu Yang China 15 167 0.8× 433 2.0× 244 1.8× 162 1.4× 10 0.1× 43 949
Baosen Li China 15 617 2.8× 196 0.9× 118 0.8× 91 0.8× 92 0.8× 32 1.2k
Shijie Zhang China 17 94 0.4× 115 0.5× 327 2.4× 26 0.2× 27 0.2× 70 831
Hassan Ehteram Iran 11 79 0.4× 71 0.3× 115 0.8× 22 0.2× 85 0.8× 32 486
Khalid Sadki Morocco 13 111 0.5× 419 2.0× 200 1.4× 121 1.1× 14 0.1× 32 705
Mark T. Lin United States 13 194 0.9× 254 1.2× 216 1.6× 50 0.4× 14 0.1× 17 1.0k
Jann Lübbe Switzerland 17 181 0.8× 125 0.6× 139 1.0× 10 0.1× 29 0.3× 32 1.1k

Countries citing papers authored by Liang Yu

Since Specialization
Citations

This map shows the geographic impact of Liang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Yu more than expected).

Fields of papers citing papers by Liang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Yu. The network helps show where Liang Yu may publish in the future.

Co-authorship network of co-authors of Liang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Liang Yu. A scholar is included among the top collaborators of Liang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang Yu. Liang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Yaohua, et al.. (2025). Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular–kidney–metabolic syndrome stages 0–3: a nationwide prospective cohort study. Cardiovascular Diabetology. 24(1). 40–40. 20 indexed citations breakdown →
2.
Ávalos, Omar, Jorge Gálvez, Liang Yu, et al.. (2024). Optimizing trigger timing in minimal ovarian stimulation for In Vitro fertilization using machine learning models with random search hyperparameter tuning. Computers in Biology and Medicine. 179. 108856–108856. 2 indexed citations
3.
Shao, Shuai, Xuefeng Zhang, Jun Hou, et al.. (2024). Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virus. npj Vaccines. 9(1). 62–62. 3 indexed citations
4.
Pei, Shiyao, Qin Ren, Liang Yu, et al.. (2021). Evaluation of vertical transmission of SARS-CoV-2 in utero: Nine pregnant women and their newborns. Placenta. 111. 91–96. 9 indexed citations
5.
Zhang, Yimin, et al.. (2020). A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System. Engineering. 7(1). 11–13. 58 indexed citations
6.
Hu, Liang, Fan Liang, Dehua Cheng, et al.. (2020). Location of Balanced Chromosome-Translocation Breakpoints by Long-Read Sequencing on the Oxford Nanopore Platform. Frontiers in Genetics. 10. 1313–1313. 38 indexed citations
7.
Hu, Jianhua, Xiaoli Zhang, Guodong Yu, et al.. (2019). Epstein-Barr virus infection is associated with a higher Child-Pugh score and may predict poor prognoses for patients with liver cirrhosis. BMC Gastroenterology. 19(1). 94–94. 7 indexed citations
8.
Li, Qifeng, Hui Zhang, Liang Yu, et al.. (2018). Regulation of IFN-γ and IL-4 by T cell Noth1 gene expression in tuberculosis patients. Chinese Journal of Asthma. 38(13). 972–977. 1 indexed citations
10.
Hu, Xinjun, Hua Zhang, Hai‐Feng Lü, et al.. (2016). The Effect of Probiotic Treatment on Patients Infected with the H7N9 Influenza Virus. PLoS ONE. 11(3). e0151976–e0151976. 17 indexed citations
11.
Bao, Qiongling, Baohong Wang, Liang Yu, et al.. (2015). A modified prognostic score for critically ill patients with cirrhosis: An observational study. Journal of Gastroenterology and Hepatology. 31(2). 450–458. 9 indexed citations
12.
Jia, Hongyu, Feng Ding, Yimin Zhang, et al.. (2015). LAM add-on ADV combination therapy or ETV monotherapy for CHB patients with suboptimal response to ADV. Annals of Hepatology. 14(2). 175–180. 5 indexed citations
13.
Zhang, Yan, Hainv Gao, Weifeng Liang, et al.. (2015). Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study. BMC Infectious Diseases. 16(1). 76–76. 25 indexed citations
14.
Yang, Meifang, Hainv Gao, Jiajia Chen, et al.. (2015). Bacterial coinfection is associated with severity of avian influenza A (H7N9), and procalcitonin is a useful marker for early diagnosis. Diagnostic Microbiology and Infectious Disease. 84(2). 165–169. 13 indexed citations
15.
Malik, Manasi, J.W. Chiles, Hualin Simon Xi, et al.. (2015). Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia. Human Molecular Genetics. 24(12). 3557–3570. 64 indexed citations
16.
Zhang, Yinxin, Yuqi Wang, Tao Liu, et al.. (2013). Analysis of hepatitis B virus genotyping and drug resistance gene mutations based on massively parallel sequencing. Journal of Virological Methods. 193(2). 341–347. 10 indexed citations
17.
Liu, Shuyuan, Chang-Jun Zhang, Peng Haiying, et al.. (2010). CAG-repeat variant in the polymerase γ gene and male infertility in the Chinese population: a meta-analysis. Asian Journal of Andrology. 13(2). 298–304. 7 indexed citations
18.
Zhou, Jingjiao, Danyun Fang, Jie Fu, et al.. (2009). Infection and replication of avian influenza H5N1 virus in an infected human. Virus Genes. 39(1). 76–80. 11 indexed citations
19.
Fu, Jie, et al.. (2007). Molecular characterization of the surface glycoprotein genes of an H5N1 influenza virus isolated from a human in Guangdong, China. Archives of Virology. 152(8). 1515–1521. 8 indexed citations
20.
Tan, Jinsong, et al.. (2007). An analysis of the characteristics of Chinese listed companies’ independent director system. Frontiers of Business Research in China. 1(3). 456–481. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026